| Document |
Document Title |
|
WO/2023/246135A1 |
The present disclosure relates to a peptide, a peptide-modified SIS membrane, a method for preparing same, and use thereof. Specifically, the present disclosure relates to an oligopeptide, a chimeric peptide containing the oligopeptide, ...
|
|
WO/2023/248845A1 |
The present invention provides: a novel PTX3 expression control agent that uses miRNA from fine particles to control PTX3 expression, the PTX3 expression control agent including fine particles that include miRNA that targets a gene relat...
|
|
WO/2023/249458A1 |
The present invention relates to: a composition comprising a CPNE7 protein or a CPNE7 protein-derived functional peptide (selcopintide) for removing reactive oxygen species in cells; a polynucleotide encoding the peptide; an expression v...
|
|
WO/2023/246827A1 |
The present invention relates to the technical field of biological medicines, and particularly, to a micromolecular drug-oligonucleotide conjugate and use thereof. The present invention solves the problems of poor water solubility and di...
|
|
WO/2023/248196A1 |
The present application relates for a peptide-ionic liquid conjugate for the prevention and/or treatment of skin disorders. The peptide- ionic liquid conjugate comprises a cosmeceutical peptide comprising up to 10 amino acids and at leas...
|
|
WO/2023/249449A1 |
The present application relates to a pharmaceutical composition for wound treatment . Specifically, the present application concerns a composition including a wound-coating material and chemokine-adsorbing particles to absorb inflammator...
|
|
WO/2023/245291A1 |
Therapeutic compositions, kits, and methods and uses thereof are provided. The compositions comprise zinc oxide, hydrocortisone, and/or clotrimazole.
|
|
WO/2023/247870A1 |
The present invention relates to a cosmetic or dermatological composition comprising at least one substituted or unsubstituted polylysine dendrimer, at least one vitamin and at least one cosmetically and/or dermatologically acceptable ca...
|
|
WO/2023/250181A1 |
Provided is a compound having the structure of Formula (1) or a pharmaceutically acceptable salt, hydrate, solvate or isotope thereof, wherein A, B, Ri, R2, R3, R4, R5, R6, R7, m, 11, p, and y are as defined herein, for use in methods fo...
|
|
WO/2023/249017A1 |
The present invention uses a lactic acid bacteria fermentation product of sap of a plant of the genus Betula as an active ingredient of an anti-aging agent, hair growth agent, and anti-androgen agent. An anti-aging agent, hair growth age...
|
|
WO/2023/245256A1 |
The present disclosure relates generally to antimicrobial gels. In particular, the present disclosure relates to an antimicrobial gel comprising a eutectic solvent and a gelling agent which can be used as a drug delivery vehicle for anti...
|
|
WO/2023/250513A1 |
Provided are 13-membered macrolides that can be used to treat proliferative diseases such as cancer as well as genetic diseases that are associated with a premature termination codon mutation or other nonsense mutations. The compounds ca...
|
|
WO/2023/247796A1 |
The present disclosure relates to a skin care composition comprising boswellic acids and vitamin B12 or derivatives thereof. The compositions can be advantageously used in a method of treatment of dermatological conditions, disorders or ...
|
|
WO/2023/242007A1 |
The present invention relates to the use of selected UV filters selected from the group consisting of octocrylene, ethyl hexyltriazone and butyl methoxydibenzoylmethane for the concomitant protection of skin bacteria of the genus Lactoba...
|
|
WO/2023/244132A1 |
The present invention refers to a potent inhibitor of the transforming growth factor beta (TGFβ) receptor I (TβRI), galunisertib (LY2157299), for use in the treatment of androgenic alopecia (AGA), acting against TGFβ repressive signal...
|
|
WO/2023/245016A1 |
The present disclosure relates to cyclic oligopeptides that bind to interleukin-13 (IL-13) which are useful therapeutically in methods of treating or preventing IL-13-associated skin disorders or conditions. The present disclosure also p...
|
|
WO/2023/240379A1 |
Provided in the present invention are an imidazolinone derivative and the use thereof. The imidazolinone derivative is a compound having a structure as shown in the following formula (I) or (II) or a pharmaceutically acceptable salt, ste...
|
|
WO/2023/243935A1 |
The present invention relates to a pharmaceutical composition for preventing or treating acne. More specifically, the present invention comprises antibiotics, bentonite, kaolin clay, corn starch, agar, titanium dioxide (TiO2), and talc, ...
|
|
WO/2023/243924A1 |
The present invention relates to a novel Micrococcus terreus strain, a disrupted solution thereof, a culture medium, an extract of the culture medium, and a use thereof for improving skin condition. The strain has a skin condition-improv...
|
|
WO/2023/242605A1 |
The invention relates to algal extracellular vesicles (EVs) for use in therapy and in restoring or maintaining health of a subject. In particular the invention relates to uses of algal EVs in therapy, wherein the EVs themselves have favo...
|
|
WO/2023/243689A1 |
The present invention provides: a sepsis and/or septic shock therapeutic agent containing, as an active ingredient, a compound that suppresses phosphorylation of threonine at position 749 of human STAT1; a method for screening a candidat...
|
|
WO/2023/242338A1 |
The present invention relates to a method for producing acylated derivate of polyphenols comprising α-glucosylation of the phloretin with a sucrose phosphorylase mutant from T. thermosaccharolyticum and acylation with the lipase from Th...
|
|
WO/2023/243166A1 |
The present invention addresses the problem of effectively promoting granulation in a dermal defect or a subcutaneous tissue defect caused by a severe burn. To solve this problem, provided is a cell to be used for treating a burn, said c...
|
|
WO/2023/242008A1 |
The present invention relates to the use of selected UV filters selected from the group consisting of octocrylene, ethyl hexyltriazone and butyl methoxydibenzoylmethane for the protection of skin bacteria of the genus Lactobacillus such ...
|
|
WO/2023/241716A1 |
Provided is use of a protein synthesis inhibitor in promoting regeneration and repair capacity of mammal tissues or complex structures or organs. The protein synthesis inhibitor is a small molecule compound, from any of cycloheximide or ...
|
|
WO/2023/241119A1 |
Disclosed is use of chaetocin in anti-aging. The present invention adopts an aging cell model and an aging mouse model to screen and obtain a drug, chaetocin, which has the effect of anti-aging. By means of cell and mouse experiment veri...
|
|
WO/2023/244738A1 |
Methods for treating a disease, condition, or disorder associated with impaired muscle regeneration, including a muscular dystrophy, such as Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), or limb-girdle muscular d...
|
|
WO/2023/242006A1 |
The present invention relates to the use of selected UV filters selected from the group consisting of octocrylene, ethylhexyl salicylate and butyl methoxydibenzoylmethane to reduce the abundance of C. acnes strains in a skin microbiome a...
|
|
WO/2023/244666A1 |
The present disclosure relates to skincare compositions that include sunflower sprout extract for treating skin conditions. More specifically, novel aspects are directed to a metabolomics guided, bioprocess engineered sunflower sprout ex...
|
|
WO/2023/242339A1 |
The subject matter of the present invention relates to a composition having hepatoprotective effect and comprising petasin and isopetasin, its use as dietary food item, food supplement, medicinal product, pharmaceutical composition or dr...
|
|
WO/2023/243447A1 |
The purpose is to clarify the internal structures of the skin related to sagging and to provide a novel cosmetic method for preventing and improving sagging. Firmness of the skin was discovered to be due to circular collagen in the dermi...
|
|
WO/2023/241717A1 |
Provided is use of a substance capable of up-regulating ISG gene expression in preparing a drug or reagent for promoting the regeneration and repair capacity of tissues or complex structures or organs of mammals. The substance for up-reg...
|
|
WO/2023/241715A1 |
Provided is use of a retinoic acid receptor activator or a composition containing the retinoic acid receptor activator in preparing a drug or reagent for promoting the regeneration and repair capacity of tissues or complex structures or ...
|
|
WO/2023/243835A1 |
The present invention relates to bacteriophage having the ability to kill Cutibacterium acnes and, more specifically, to bacteriophage CAP-1 having the ability to kill Cutibacterium acnes, which proliferates on the skin and induces infla...
|
|
WO/2023/245053A1 |
The present disclosure is related to solid forms of ruxolitinib di-hydrate and ruxolitinib free base, process of preparing the same, and compositions comprising the same.
|
|
WO/2023/243900A1 |
The present invention relates to an acne relief and prevention patch with excellent skin adhesion and suggests an acne relief and prevention patch that comprises a biodegradable metal thin plate 0.7 mm or less in thickness and an adhesio...
|
|
WO/2023/235929A1 |
The present disclosure relates generally to compounds with anti-cancer and/or anti-fibrotic properties. In particularn the disclosure relates to functionalised benzopyran compounds, the preparation thereof, and their use.
|
|
WO/2023/238910A1 |
The present invention provides a skin health condition improving agent characterized by containing a sterol ester that is obtained from rice bran.
|
|
WO/2023/238945A1 |
An oleanane-type triterpenoid or a glycoside thereof that is useful as a compound having effects of inducing fine hair formation and activating hair papilla cells and hair matrix cells.
|
|
WO/2023/238901A1 |
The purpose of the present invention is to provide a cacao-derived composition containing a free ceramide, as well a moisturizer, a skin texture improving agent, a hair texture improving agent, a skin cosmetic, a hair cosmetic, a pharmac...
|
|
WO/2023/238416A1 |
The present invention provides a hair-growing or hair-fostering agent which exhibits a high hair-growing or hair-fostering effect but has no or few side effects. Specifically, provided is a hair-growing or hair-fostering agent containing...
|
|
WO/2023/238773A1 |
[Problem] To provide a viable bacteria count regulation agent for more reliably regulating the viable bacteria count of Propionibacterium acnes present on the skin surface and for improving cutaneous conditions. [Solution] One embodiment...
|
|
WO/2023/237677A1 |
The present invention relates to a combination comprising vitamin C and Bifidobacterium animalis ssp. lactis and its use for improving gut health in animals and humans. It was found that a combination of vitamin C and Bifidobacterium ani...
|
|
WO/2023/238056A1 |
The invention provides a composition for use in decreasing lipid production in sebocytes or in the skin of an individual, the composition comprising a triterpenoid compound according to formula (I) as described herein, or a pharmaceutica...
|
|
WO/2023/239148A1 |
The present invention provides a composition for promoting hair growth or preventing hair loss, the composition comprising an exosome derived from rose stem cells as an effective ingredient. The composition including an exosome derived f...
|
|
WO/2023/235935A1 |
Disclosed herein are compositions that are formulated for topical use. The compositions may comprise microparticles, at least one bioactive compound, and optionally a penetration enhancer. Also disclosed herein are uses of the compositio...
|
|
WO/2023/238899A1 |
The purpose of the present invention is to provide a cacao-derived composition containing free ceramide, and a moisturizer, skin improving agent, hair improving agent, skin cosmetic, hair cosmetic, pharmaceutical composition, and food co...
|
|
WO/2023/237689A1 |
The present invention relates to a combination comprising vitamin C and Lactobacillus rhamnosus and its use for improving gut health in animals and humans. It was found that a combination of vitamin C and Lactobacillus rhamnosus, when de...
|
|
WO/2023/237673A1 |
The present invention relates to a combination comprising vitamin C and Bifidobacterium animalis ssp. lactis and its use for improving gut health in animals and humans. It was found that a combination of vitamin C and Bifidobacterium ani...
|
|
WO/2023/237481A1 |
The invention relates to a composition for preventing and/or treating, in a subject, the early stage of vitiligo corresponding to the dysregulation of the mitochondrial function, keratinocytes and melanocytes, associated with an abnormal...
|
